Compare SWK & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWK | NBIX |
|---|---|---|
| Founded | 1843 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 15.5B |
| IPO Year | 2009 | 1996 |
| Metric | SWK | NBIX |
|---|---|---|
| Price | $96.47 | $158.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 22 |
| Target Price | $84.00 | ★ $180.91 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.38% | N/A |
| EPS Growth | 35.90 | ★ 41.95 |
| EPS | 2.71 | ★ 3.30 |
| Revenue | ★ $15,130,400,000.00 | $161,626,000.00 |
| Revenue This Year | $1.56 | $24.73 |
| Revenue Next Year | $2.10 | $13.14 |
| P/E Ratio | ★ $35.58 | $47.95 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $61.90 | $122.14 |
| 52 Week High | $104.68 | $186.12 |
| Indicator | SWK | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 48.20 |
| Support Level | $85.62 | $153.96 |
| Resistance Level | $101.27 | $161.29 |
| Average True Range (ATR) | 2.54 | 3.58 |
| MACD | -0.88 | 0.89 |
| Stochastic Oscillator | 33.28 | 76.22 |
Stanley Black & Decker Inc offers hand tools, power tools, outdoor products, engineered fastening solutions, and related accessories. The company operates in two reportable business segments: Tools & Outdoor and Engineered Fastening. The majority of its revenue is generated from the Tools & Outdoor segment, which is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) product lines. This segment's product offerings include drills, impact wrenches and drivers, grinders, saws, hammers, demolition tools, clamps, vises, knives, edge trimmers, lawn mowers, etc., which are offered through brands like Hustler, Dewalt, Craftsman, Stanley, and others. Geographically, the firm derives maximum revenue from the United States.
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.